Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced Solid Tumors|Metastatic Pancreatic Cancer|Pediatric Solid Tumor|Advanced Breast Cancer|Malignant Peripheral Nerve Sheath Tumor|Colorectal Neoplasms
Interventions: DRUG: Metarrestin
Sponsor: National Cancer Institute (NCI)